You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?

Article info

Article menu

Download PDFPDF

Immunotherapy biomarkers
Short report
Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?

Authors

  • Ferdinand Seith Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Andrea Forschner Dermatology, Eberhard Karls University Tübingen, Tübingen, Baden-Württemberg, Germany PubMed articlesGoogle scholar articles
  • Benjamin Weide Dermatology, Eberhard Karls University Tübingen, Tübingen, Baden-Württemberg, Germany PubMed articlesGoogle scholar articles
  • Brigitte Gückel Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Martin Schwartz Section on Experimental Radiology, Eberhard Karls University Tübingen, Tubingen, Germany PubMed articlesGoogle scholar articles
  • Johannes Schwenck Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University Tübingen, Tubingen, Baden-Württemberg, Germany Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Tübingen, Baden-Württemberg, Germany Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University, 72076 Tübingen, Germany PubMed articlesGoogle scholar articles
  • Ahmed E Othman Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Matthias Fenchel Diagnostic Imaging, Magnetic Resonance, Siemens Healthcare GmbH, Erlangen, Bayern, Germany PubMed articlesGoogle scholar articles
  • Claus Garbe Dermatology, Eberhard Karls University Tübingen, Tübingen, Baden-Württemberg, Germany PubMed articlesGoogle scholar articles
  • Konstantin Nikolaou Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University, 72076 Tübingen, Germany PubMed articlesGoogle scholar articles
  • Nina Schwenzer Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Christian la Fougère Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University Tübingen, Tubingen, Baden-Württemberg, Germany Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University, 72076 Tübingen, Germany PubMed articlesGoogle scholar articles
  • Christina Pfannenberg Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ferdinand Seith; ferdinand.seith{at}med.uni-tuebingen.de
View Full Text

Citation

Seith F, Forschner A, Weide B, et al
Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?
Journal for ImmunoTherapy of Cancer 2020;8:e000656. doi: 10.1136/jitc-2020-000656

Publication history

  • Accepted June 25, 2020
  • First published August 4, 2020.
Online issue publication 
August 04, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.